COMPANY PROFILE
| Price and Volume | |
|---|---|
| Recent Price | 3.58 |
| 52 Week High | 5.75 |
| 52 Week Low | 0.40 |
| Avg. Daily Vol. (Mil) | 0.49 |
| Beta (3 year) | 2.71 |
| Share Related Items | |
| Mkt Cap (Mil) | 135.27 |
| Shares Out (Mil) | 49.95 |
| Float (Mil) | 34.37 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 3.60 |
| Current Ratio | 5.40 |
| LT Debt/ Equity | 0.57 |
| Total Debt / Equity | 0.58 |
| Valuation Ratios | |
| Price Earnings | 2.20 |
| Price/Sales | 0.28 |
| Price/Book | 0.38 |
| Price/Cash Flow | 1.40 |
| Per Share Data | |
| Earnings | 1.66 |
| Sales | 12.74 |
| Book Value | 9.31 |
| Cash Flow | 2.57 |
| Business Summary | |
|---|---|
| The Company and its subsidiaries are engaged in the development, manufacture, acquisition, marketing and sale of technologically distinguished branded and generic/non-branded prescription pharmaceutical products. | |
| General Information | |
| 2503 South Hanley Road
St. Louis, MO 63144 |
|
| www.kvpharma.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 1590 | |
| CEO: David A. Van Vliet | |
| Short Interest | |
| Current Month (Mil) | 2.34 |
| Previous Month (Mil) | 2.19 |
| Short Interest Ratio (Days) | 3.70 |
| Management Effectiveness | |
| Return on Equity | 20.40 |
| Return on Assets | 10.80 |
| Return on Investments | 12.90 |
| Profitability | |
| Gross Margin | 72.80 |
| EBIT Margin | 23.90 |
| Profit Margin | 14.90 |